Gilead Sciences, Inc. will modify its Advancing Access patient and medication assistance programs for HIV and chronic hepatitis B drugs starting in January 2022 by reimbursing pharmacies and clinics that provide the drugs for free to uninsured patients at the same price as the providers acquired them.
That means pharmacies purchasing the drugs at 340B discounted prices will be reimbursed by Gilead at the same discounted rate...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?